Literature DB >> 2076386

Excessive mural calcium overload--a predominant causal factor in the development of stenosing coronary plaques in humans.

A Fleckenstein1, M Frey, F Thimm, G Fleckenstein-Grün.   

Abstract

Healthy human coronary artery walls contain, over their entire lifetime, more free and total cholesterol than calcium. However, as soon as arteriosclerotic alterations set in, the calcium content increases. Thus in coronary fatty streaks (arteriosclerotic plaques of WHO stage I), calcium was increased 13 times, in stage II plaques 25 times, and in fully developed stage III plaques 80 times above normal on average. The most dramatic calcium incrustation was found in coronary stage III plaques that had produced massive fatal coronary infarction. Here, the proportion of calcium salts (particularly hydroxyapatite) may amount to almost 50% of dry weight. Thus the most excessive accumulation of calcium seems to be correlated with the highest fatality. In contrast, there is no correlation between mural coronary free or total cholesterol content, and plaque severity. Accordingly, stenosing coronary stage III plaques contain less cholesterol than do fatty streaks. Moreover, in coronary stage III plaques the proportion of free cholesterol was 1.37%, and of total cholesterol only 2.34% of the whole mass, certainly not enough for directly causing coronary occlusion. Thus the calcium-rich plaques of human coronary arteries considerably differ from the well-known cholesterol-rich plaques (stage I and II) of human aortae. Our findings justify a new prophylactic approach with suitable calcium antagonists to interfere with deleterious calcium uptake in coronary plaque development.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2076386     DOI: 10.1007/BF02018309

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  17 in total

1.  VITAMIN D-INDUCED AORTIC CALCIFICATION.

Authors:  R EISENSTEIN; L ZERUOLIS
Journal:  Arch Pathol       Date:  1964-01

2.  Experimental arteriosclerosis due to hypervitaminosis D.

Authors:  G M HASS; R E TRUEHEART; A HEMMENS
Journal:  Am J Pathol       Date:  1960-11       Impact factor: 4.307

3.  A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity.

Authors:  L L ABEL; B B LEVY; B B BRODIE; F E KENDALL
Journal:  J Biol Chem       Date:  1952-03       Impact factor: 5.157

Review 4.  Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle.

Authors:  A Fleckenstein
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

Review 5.  Factors affecting arterial calcification associated with atherosclerosis. A review.

Authors:  J Yogamundi Moon
Journal:  Atherosclerosis       Date:  1972 Jul-Aug       Impact factor: 5.162

6.  Ca overload as the determinant factor in the production of catecholamine-induced myocardial lesions.

Authors:  A Fleckenstein; J Janke; H J Döring; O Pachinger
Journal:  Recent Adv Stud Cardiac Struct Metab       Date:  1973

7.  [On the action mechanism of new coronary dilators with simultaneous oxygen saving myocardial effects, Prenylamine and Iproveratril. 1].

Authors:  A Fleckenstein; H Kammermeier; H J Döring; H J Freund
Journal:  Z Kreislaufforsch       Date:  1967-07

Review 8.  Model experiments on anticalcinotic and antiarteriosclerotic arterial protection with calcium antagonists.

Authors:  A Fleckenstein
Journal:  J Mol Cell Cardiol       Date:  1987-05       Impact factor: 5.000

9.  Key role of Ca in the production of noncoronarogenic myocardial necroses.

Authors:  A Fleckenstein; J Kanke; H J Döring; O Leder
Journal:  Recent Adv Stud Cardiac Struct Metab       Date:  1975

Review 10.  Antihypertensive and arterial anticalcinotic effects of calcium antagonists.

Authors:  A Fleckenstein; M Frey; G Fleckenstein-Grün
Journal:  Am J Cardiol       Date:  1986-02-26       Impact factor: 2.778

View more
  3 in total

1.  Overexpression of SERCA2 Atpase in vascular smooth muscle cells treated with oxidized low density lipoprotein.

Authors:  H Massaeli; J A Austria; G N Pierce
Journal:  Mol Cell Biochem       Date:  2000-04       Impact factor: 3.396

Review 2.  Atherosclerosis: inhibition of regression as therapeutic possibilities.

Authors:  M J Davies; D M Krikler; D Katz
Journal:  Br Heart J       Date:  1991-06

Review 3.  Calcium overload--an important cellular mechanism in hypertension and arteriosclerosis.

Authors:  G Fleckenstein-Grün; M Frey; F Thimm; W Hofgärtner; A Fleckenstein
Journal:  Drugs       Date:  1992       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.